Browse articles from EyeWorld.org related to crosslinking. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ New visual prosthesis heads to clinical trial ➤ FDA grants Fast Track designation to investigational wet AMD therapy ➤ Patient enrollment complete in Phase 3 trial for investigational, first-in-class eye drop for DED ➤ FDA agrees to pivotal trial design for investigational treatment of geographic atrophy secondary to AMD ➤ ASCRS news and events
➤ Early termination of study evaluating Beovu ➤ NDA resubmitted to FDA for investigational macular edema treatment ➤ First peer-reviewed paper on visual recovery in a blind patient treated with optogenetic therapy ➤ Study: New riboflavin formulation enhances transepithelial crosslinking ➤ Enrollment complete for blepharitis trial ➤ Companies partner to develop human-induced pluripotent stem cell-derived therapies for ocular diseases ➤ ASCRS events
➤ Positive topline results in Phase 3 study for temporary presbyopia therapy ➤ Study: New therapy for ocular infections ➤ Analysis of more than half a million cataract surgeries yields PCO insights ➤ Patients blinded from AMD benefit from visual prosthetic ➤ New company focuses on refractive pharmaceutical treatments ➤ ASCRS events
The success of any surgical intervention depends as much on postoperative care and management as it does on the surgical procedure itself. This undoubtedly also holds true for corneal crosslinking. At our hospital, we have been performing corneal crosslinking with the IROC illumination system since the development of the first prototype and continue to use the latest UV-X 2000 crosslinking device.
When will my vision stabilize after crosslinking? Could my keratoconus symptoms return? What complications might occur? Patients undergoing crosslinking have many questions, and CXL pros have the answers.
Get the latest ophthalmology news delivered to your inbox every Friday.